EZH2-IN-4


Catalog No. Size PriceQuantity
M17774-C Contact sales@xcessbio.com for quotation $100Unavailable

Description

EZH2-IN-4 is an orally active, potent EZH2 inhibitor with IC50s of 0.923 nM and 2.65 nM against wild type (WT) 5-membered (5-mer) EZH2 and mutant 5-mer EZH2, respectively. EZH2-IN-4 has anti-cancer activity.

Product information

CAS Number: 2088132-99-2

Molecular Weight: 511.72

Formula: C29H41N3O3S

Chemical Name: 7-((4, 6-dimethyl-2-oxo-1, 2-dihydropyridin-3-yl)methyl)-2-((R)-1-((1r, 4R)-4-(3-methoxyazetidin-1-yl)cyclohexyl)ethyl)-3-methyl-4, 5, 6, 7-tetrahydro-8H-thieno[2, 3-c]azepin-8-one

Smiles: C[C@H]([C@@H]1CC[C@H](CC1)N1CC(C1)OC)C1SC2=C(CCCN(CC3C(=O)NC(C)=CC=3C)C2=O)C=1C

InChiKey: NSJLNLBLBQQSDY-CEMLEFRQSA-N

InChi: InChI=1S/C29H41N3O3S/c1-17-13-18(2)30-28(33)25(17)16-31-12-6-7-24-20(4)26(36-27(24)29(31)34)19(3)21-8-10-22(11-9-21)32-14-23(15-32)35-5/h13,19,21-23H,6-12,14-16H2,1-5H3,(H,30,33)/t19-,21-,22-/m1/s1

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

How to use

In Vitro:

EZH2-IN-4 (example 38) shows a cell H3K27me3 IC50 of 0.00973 nM in Karpas-422 (EZH2 Y641N) cells. EZH2-IN-4 shows an IC50 of 10.1 nM in Plate Kj«pas-422 cells. EZH2-IN-4 inhibits the proliferation of ovarian cancer cell lines (COV-434, TOV-21G, TOV-112D, A2780, Caov-3, OVCAR3; IC50s=0.02-8.6 μM) and has no effect on SKOV3, HeyA8, HEC59 cell (IC50>20 μM).

In Vivo:

EZH2-IN-4 (example 38; oral gavage; 15 mpk; BID) results in 73% inhibition of tumor methylation in the Karpas-422 xenograft model. EZH2-IN-4 (po; 50 mpk; twice a day; pretreatment for 5 days; followed by co-administration with gemcitabine plus cisplatin for at least 23 additional days) significant inhibits A2780 tumor growth in A2780 xenograft model.

Products are for research use only. Not for human use.

Payment & Security

PayPal Venmo

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

You may also like

Recently viewed